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Abstract
Background: Androgen acts via androgen receptor (AR) and accurate measurement of the levels
of AR protein expression is critical for prostate research. The expression of AR in paired
specimens of benign prostate and prostate cancer from 20 African and 20 Caucasian Americans
was compared to demonstrate an application of this system.
Methods: A set of 200 immunopositive and 200 immunonegative nuclei were collected from the
images using a macro developed in Image Pro Plus. Linear Discriminant and Logistic Regression
analyses were performed on the data to generate classification coefficients. Classification
coefficients render the automated image analysis software independent of the type of
immunostaining or image acquisition system used. The image analysis software performs local
segmentation and uses nuclear shape and size to detect prostatic epithelial nuclei. AR expression
is described by (a) percentage of immunopositive nuclei; (b) percentage of immunopositive nuclear
area; and (c) intensity of AR expression among immunopositive nuclei or areas.
Results: The percent positive nuclei and percent nuclear area were similar by race in both benign
prostate hyperplasia and prostate cancer. In prostate cancer epithelial nuclei, African Americans
exhibited 38% higher levels of AR immunostaining than Caucasian Americans (two sided Student's
t-tests; P < 0.05). Intensity of AR immunostaining was similar between races in benign prostate.
Conclusion: The differences measured in the intensity of AR expression in prostate cancer were
consistent with previous studies. Classification coefficients are required due to non-standardized
immunostaining and image collection methods across medical institutions and research laboratories
and helps customize the software for the specimen under study. The availability of a free,
automated system creates new opportunities for testing, evaluation and use of this image analysis
system by many research groups who study nuclear protein expression.
Background
Benign prostate hyperplasia affects most men and often
causes lower urinary tract symptoms. Prostate cancer leads
in the number of estimated new cases diagnosed each year
and is the second leading cause of cancer specific mortal-
ity in American men [1]. The development of the prostate,
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genesis and progression require androgenic stimulation
[2]. Since androgen acts via androgen receptor (AR), AR
expression in prostatic cells may play a central role in
prostate pathology. AR belongs to the steroid receptor
superfamily, which includes estrogen, progesterone, corti-
costeroids, vitamin D, thyroid, and retinoic acid receptors
[3]. A study using radiolabeled natural and synthetic AR
ligands showed the presence of AR in normal prostate,
benign prostate and prostate cancer [4]. High levels of AR
are associated with increased proliferation, markers of
aggressive disease and are predictive of decreased bio-
chemical recurrence-free survival independently, confirm-
ing the role of AR in tumor growth and progression in
hormonally naive prostate cancer [5].
AR protein expression was assessed first using visual scor-
ing of immunostained sections of prostate tissue. A visual
scoring technique developed by Miyamoto et al. [6]
assessed intensity of AR immunostaining on a scale of 0
(none) to intense (3+) for each nucleus. However, recog-
nition of malignant nuclei requires a skilled pathologist
or a highly trained technician and visual assignment of
immunopositivity is subjective, tedious and poorly repro-
ducible. Mean optical density (MOD) measured using
image analysis was found more accurate and reproducible
for measuring AR expression but object identification
remained difficult. Investigators used a light pen to encir-
cle [7] or a sampling window [8] to select areas of malig-
nant nuclei for optical density measurement. However,
these interactive image analysis methods are tedious and
user bias influences the measurements. Tilley et al. [9]
used an automated color video image analysis system to
measure MOD of each positively stained area in visually
marked malignant tissue. MOD was calculated as the total
integrated optical density divided by the area. Such meas-
urements tend to be less accurate when compared to
MOD measured from individual nuclei. In addition,
MOD depends on variability of immunostaining intensity
among tissue sections and tissue thickness [7-9].
Segmentation of prostatic epithelial nuclei from complex
histological images and classification of nuclei as malig-
nant or benign posed a significant challenge to accurately
quantifying AR expression by image analysis. This barrier
was overcome by combining segmentation algorithms
and nuclear morphometry. Qualitative nuclear mor-
phometry was used to characterize the aggressiveness of
prostate cancer [10,11]. Kim et al [12] developed a semi-
automated technique to identify individual prostatic epi-
thelial nuclei and classify each nucleus as benign or malig-
nant using nuclear shape descriptors. Segmentation of
malignant prostatic nuclei allowed application of conven-
tional image analysis algorithms to measure AR expres-
sion. A combination of CAS-200 image analysis system
with Cell Sheet v2.0 and nuclear morphometric descrip-
tors (NMD) has been used to develop quantitative nuclear
grade (QNG), for making clinical, diagnostic and prog-
nostic outcome predictions in prostate cancer [13].
Macros written in commercially available image analysis
software such as Adobe Photoshop [14], Optimas [15]
and Image Pro Plus [16] have also been used to perform
semi-automated image analysis. User interaction is
required for object (nuclei) selection, modification of
object boundaries and/or selection of thresholds. Dedi-
cated image analysis systems like CAS-200 [17], ACIS [18]
and Autocyte [19] are employed in the determination of
nuclear features from immunostained images. These sys-
tems use dedicated hardware and proprietary software
and typically require manual interaction. Schnorrenberg
et al. [20] developed an algorithm for automated analysis
of breast cancer biopsies. The algorithm transforms the
color image into bimodal distribution and identifies the
presence and intensity of only the positively immunos-
tained nuclei. Xu et al. [21] developed a software package
for automated labeling of rat liver nuclei by integrating
various commercial software using macros and Visual
Basic. Loukas et al [22] used LabWindows libraries to
develop an application for automated counting of nuclei
in squamous cell carcinomas of the head and neck.
Our image analysis system was developed on networked
DEC 5000 workstations, and used programs written in
C++, Windows-based Statgraphics 4.1 and Optimas 6.0
[23-25]. The C++ programs incorporated graphics and
image processing libraries (IGLOO) [26]. The image anal-
ysis programs were later ported to a PC compatible system
on a Linux platform. However, images were collected
using Windows-based systems that required image trans-
fer across platforms. The current image analysis software
was developed on a Java platform and incorporates all fea-
tures of previous versions. The software eliminates the
need for Statgraphics and Optimas and can be deployed
on a variety of platforms with several versions of the soft-
ware running at the same time without conflict [27]. The
program is associated with a Web browser and can be
downloaded freely from our website [28]. Once down-
loaded, Web connection is no longer required.
The image analysis software can be divided into four mod-
ules: a) detection of potential prostate nuclei; b) removal
of artifacts; c) classification of prostate epithelial nuclei
and d) measurement of AR expression. Human interven-
tion is only required to create a set of classification param-
eters. These parameters are used to reduce the effect of
local variations in slide preparation and image acquisition
on nuclear measurements. The software identifies arti-
facts, distinguishes epithelial prostate nuclei from
endothelial and stromal nuclei and inflammatory cellsPage 2 of 9
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ters are used to differentiate between immunopositive
and immunonegative nuclei. AR expression is quantified
by (a) percentage of immunopositive nuclei; (b) percent-
age of immunopositive nuclear area; and (c) intensity of
AR expression among immunopositive nuclei or areas.
The development and operation of an automated image
analysis system are described. A preliminary study com-
paring AR expression in paired specimens of benign pros-
tate and prostate cancer from 20 African and 20 Caucasian
Americans is presented to demonstrate an application of
this system.
Hardware and Software
1. Hardware specifications
The imaging system consists of a Leica DMRA2 micro-
scope (Leica Microsystems Inc, Bannockburn, IL) with a
Ludl motorized stage controller (Ludl Electronic Products
Ltd, Hawthorne, NY), a Hamamatsu 3 Chip CCD camera
with controller (Hamamatsu, Bridgewater, NJ) and a
Flashpoint 3D image grabber card (Integral Technologies,
Indianapolis, IN) in a Pentium IV based PC. The PC used
is a Dell Optiplex GX240 (Dell Inc, Round Rock, Texas)
with 1.8 GHz Pentium IV processor and 512 Mb RAM.
Image Pro Plus 4.5 (Media Cybernetics Inc. Silver Spring,
Maryland) software on Windows 2000 (Microsoft Corp,
Redmond, Washington) platform was used for image
acquisition and Linux based Dell Precision 530 and Win-
dows based Dell Precision 340 were used for image
analysis.
2. Software
Java Runtime Environment (Sun Microsystems, Santa
Clara, CA) provides the platform to run the image analysis
software. Once Java has been installed, the image analysis
software can be launched from our web page [25]. Once it
is cached on the local computer, Web connection is not
required.
2.1. Macro for obtaining RGB data
A macro written in Visual Basic (Microsoft Corp, Red-
mond, WA) is used to obtain area and RBG color informa-
tion from selected regions of the image. The macro was
developed in Image Pro Plus 4.5. The macro prompts the
user at every step of the process. The user is prompted to
open an image and select immunopositive and immu-
nonegative nuclei. The macro guides the user to select
individual nuclei using tools provided by Image Pro. The
macro calculates the area (in pixels) and the mean RGB
color values (0–255) of the pixels enclosed in the selected
region. The data is automatically transferred to Microsoft
Excel. A numerical tag is attached to each set of values
from immunopositive and immunonegative nuclei.
2.2. Overview of application software
The application program is divided into two modules.
A. Classification table
Data obtained from the macro (Section 2.2.1) is input to
the program under 'Parameter Training'. The program
checks the input data file format and displays it in a new
window. The results of the analysis, 'Classification Table',
are shown in a new window. Once the user is satisfied and
accepts the results, a new set of classification parameters is
created and stored.
B. Image analysis
If a classification parameter dataset already exists, it is
loaded into the program by clicking on 'Browse' and locat-
ing the file. Parameters can also be entered manually by
clicking on 'Modify' (under Config File). The location of
the output directory is set by clicking on 'Browse' under
Output Directory. Files are added and removed by click-
ing on 'Add' and 'Delete' buttons on Input Files frame.
The output data files are stored in short (final results only)
or long (results from individual nuclei) format with the
same prefix as the input image file name. Images created
during image analysis can be reviewed and stored by
checking corresponding boxes under File in the main win-
dow. The graphical user interface (GUI) of the image anal-
ysis software is shown in figure 1.
Graphical user interface (GUI) of the image analysis softwareFigure 1
Graphical user interface (GUI) of the image analysis software.Page 3 of 9
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1. Study specimens
Prostate tissue specimens were obtained from archived,
paraffin-embedded blocks of radical prostatectomy speci-
mens. The expression of AR in paired specimens of benign
prostate and prostate cancer from 20 African and 20 Cau-
casian Americans was compared to demonstrate an appli-
cation of this system. Clinical data from these specimens
was obtained from prospectively maintained clinical
databases.
2. Immunohistochemistry
Immunohistochemistry allows for in situ protein localiza-
tion and computer assisted image analysis of AR while
preserving tissue architecture. Polyclonal or monoclonal
antibodies target specific epitopes located within cellular
structures to visualize epitopes of interest. Archival paraf-
fin-embedded prostate specimens were cut into 6 µm sec-
tions and placed on ProbeOn Plus™ microscope slides
(Fisher Scientific, Pittsburg, PA). After deparaffination
and rehydration through graded alcohols (100%, 95%,
70%), tissue sections were subjected to antigen retrieval in
Reveal Citra buffer (Biocare Medical, Walnut Creek, CA)
using a pressurized antigen-decloaking chamber for 2
minutes at 120°C and 21 PSI. The sections were cooled to
room temperature and blocked for non-specific staining
with 2% normal horse serum for 15 minutes at 37°C.
Endogenous peroxidase was blocked using 3% hydrogen
peroxide diluted in methanol and endogenous biotin was
blocked using an Avidin Biotin kit (Vector, Burlingham,
CA). Sections were incubated using a capillary gap
method with monoclonal antihuman AR antibody
F39.4.1 (Biogenex, San Ramon, CA) diluted in Primary
Antibody Diluting Buffer (Biomeda Corp., Foster City,
CA) at 1:500 for 1 hour at 37°C in a humidified heating
block. Sections were incubated with biotinylated anti-
mouse IgG (Vector) 1:200 for 30 minutes at 37°C. The
signal was then amplified using avidin-biotin complex
(ABC) Vector and visualized using 3,3'-diaminobenzidine
(DAB) (Vector). Counterstaining was performed using
hematoxylin (Fisher Scientific) for 15 seconds (diluted
1:3 in H2O). Slides were dehydrated through graded alco-
hol and mounted using Permount (Fisher Scientific).
Benign and malignant tissues were immunostained in a
single batch.
3. Image acquisition
The images were acquired using a 40:1 objective, N.A.
0.85 for a total magnification of 400×. Contrast and
brightness were adjusted by manipulating the gain and
exposure time of the camera. Illumination was adjusted to
generate maximum contrast while avoiding over- and
under-saturation of gray levels. A series of neutral filters
were added to confirm the linearity of output in final opti-
cal settings. Temporal variation of light output was meas-
ured frequently and found insignificant (<0.2%). Images
were sampled randomly throughout histological sections,
but areas of necrosis, artifacts and edges were avoided.
Each image was captured under the same reproducible
conditions. White and Black balance of the camera was
performed to ensure the optimal use of the dynamic range
of the camera. Ten images were collected from each tissue
specimen. Each image consisted of 640 × 480 pixels col-
lected in 24-bit color mode (16.7 million colors) and was
stored in an uncompressed tagged image format file
(TIFF).
4. Creation of classification parameters
Commercial reagents used in the immunohistological
staining process are not standardized; thus immunostain-
ing patterns differ between various research labs. When
combined with local variations in image acquisition, the
resulting automated analysis may produce significant
errors. Classification parameters are used to calibrate the
nuclear analysis software with each new dataset, thus
making the automated image analysis software independ-
ent of the type of immunostaining or imaging system
used. Figure 2 shows the block diagram of the steps
involved in the creation of classification parameters.
4.1 RGB dataset
A minimum of 200 immunopositive and 200 immunon-
egative nuclei were randomly sampled from the acquired
images. Red, Green and Blue information was extracted
from the selected nuclei. A new column 'Class' was added
to the dataset. Objects identified as immunopositive are
class 1 and objects identified as immunonegative are class
2.
4.2 Classification parameters
The dataset was divided into two non-overlapping sets;
(a) training set and (b) test set. Each consists of at least
100 immunopositive nuclei and 100 immunonegative
Steps involved in the creation of classification parametersFigure 2
Steps involved in the creation of classification parameters. CP 
– Classification Parameters.Page 4 of 9
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training set using either of the following methods.
(a) Linear Discriminant Analysis
Let x = {xhue, xsaturation, xintensity} denote individual data
structure present and x1 = {x11, x12, x13..., x1n1}, x2 = {x21,
x22, x23..., x2n2} represent class 1 and class 2 datasets from
the training set with µ1, µ2 as their corresponding means
[29].
The covariance of x1 and x2 is:
The pooled covariance is given by:
Sp = (S1 + S2) / (n1 + n2 - 2)  (3)
where n1, n2 are the number of immunopositive and
immunonegative nuclei in the training set, respectively.
The classification coefficients λ = {λ1, λ2, λ3} and constant
C are computed as
C = µ λ  (5)
where S-1 is the inverse of S and µ is the mean of µ1 and µ2.
The classification function is of the form:
G(x) = λ1 xhue + λ2 xsaturation + λ3 xintensity - Constant  (6)
where G(x) is the classification score.
(b) Logistic Regression
Let x = {xhue, xsaturation, xintensity} denote individual data
structure present, X = {x1, x2, x3..., xn}, the training set and
Y represent a column vector with class information of the
test dataset. The probability of Y = 1 in a multiple logistic
regression model [30] is given as
p = 1 / (1 + e-βX)  (7)
where β is the coefficients vector. The equation can be
rewritten as
ln(p / (1-p)) = βX  (8)
Equation (8) represents the log of odds as a linear func-
tion of X. Since the values for log of odds is not available,
a maximum likelihood function provides the solution.
Each dataset can be considered as a Bernoulli trial. That is,
it is a binomial with the total number of trials equal to 1.
Consequently for the ith observation
Assuming all datasets are independent, the likelihood
function is given by
The log of the likelihood function is given by
The parameter vector β are obtained by maximizing (11)
using the efficient Newton-Raphson iterative technique.
The classification function is of the form:
G(x) = β0 + β1 xhue + β2 xsaturation + β3 xintensity  (12)
where G(x) is the classification score.
The classification function was tested on the test set. If z =
{zhue, zsaturation, zintensity} is an individual data structure in
the test set, it is classified as class 1 if G(z) > 0, otherwise,
it is class 2. The classification scores were compared with
actual scores and a classification table was constructed. If
the percentage of class 1 nuclei and class 2 nuclei identi-
fied correctly is greater than 85, then the classification
coefficients were used. If not, nuclei are randomly sam-
pled again and the process was repeated.
Limits for nuclear area are added to the parameter set to
eliminate possible artifacts in the image. The lower limit
and upper limits of nuclear area were calculated from the
dataset
Area upper = Area Mean + 2SD  (13)
Area lower = Area Mean - 2SD  (14)
where SD is the standard deviation of the nuclear area
measures.
5. Image analysis
A block diagram of the image analysis program is shown
in Figure 3. Red, green and blue color information was
extracted from the original uncompressed 24-bit color
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analysis of grayscale histograms was used to determine
optimal thresholds for automated segmentation of red,
green and blue images [31]. The adaptive threshold was
applied using an 80 × 80 pixel window. This window size
was chosen because it is about four times the size of a typ-
ical nucleus (nuclear diameter ~20 pixels). The three seg-
mented images were combined by a logical OR operation.
The combined image was eroded and dilated twice using
a 3 step erosion filter (3 × 3 cross, 1 × 3 horizontal and 3
× 1 vertical kernels). Erosion was used to shrink the
detected nuclear boundaries and dilation was used to fill
the nuclear areas. Artifacts were removed based on size
and shape. The nuclear regions were then labeled in raster
fashion to create a nuclear mask. Regions not labeled are
regarded as background.
Use of red, green and blue images to separate immunop-
ositive from immunonegative nuclei is problematic
because the color of stain is mixed with the intensity of
stain. An HSI color model was used because it decouples
intensity information from color information [32]. The
hue, saturation and intensity component images were
multiplied by their corresponding discriminant coeffi-
cients from the parameter file and combined to form a
single image. A nuclear mask was applied to the image
and the resulting nuclear areas were classified as
immunopositive or immunonegative depending on their
classification score. Figure 4 shows part of an image at dif-
ferent stages of image processing. The precise number of
nuclei measured may be inaccurate due to the presence of
nuclear overlap or clusters of nuclei. Addition of an upper
limit for nuclear area measurement creates a reproducible
error. Nuclear shape limits were also used to separate epi-
thelial nuclei from artifacts, endothelial and stromal
nuclei and inflammatory cells.
The nuclear mask was applied on the intensity image to
obtain the intensity mask image. MOD of each nuclear
area present in the image is calculated as:
where N is the total number of pixels in a nuclear mask, Ii
is the intensity level of the pixel i, and Io is the intensity
level of the background measured in each field of view.
NRF is the ratio of the radius of the circle the perimeter of
which is equivalent to the measured perimeter to the
radius of the circle of which is equivalent to the measured
area. The NRF of each nuclear object is given by:
where A is the measured nuclear area and perimeter P is
calculated using a chaining approximation, using weights
(1, 4, 6, 4, 1). More information on MOD, area and
perimeter calculations can be found in earlier publica-
tions [13,23].
Results
The classification coefficients were computed using linear
discriminant analysis and by logistic regression. There was
no statistical difference in the results obtained by the two
methods (Student's t test, P = 0.3896). The classification
table is shown in Table 1. The percent positive nuclei and
percent nuclear area were similar by race in both benign
prostate hyperplasia and prostate cancer (Table 2). In
prostate cancer epithelial nuclei, African Americans exhib-
ited 38% higher levels of AR immunostaining than Cau-
casian Americans (two sided Student's t-tests; P < 0.05).
Intensity of AR immunostaining was similar between
races in benign prostate.
Block diagram of the image analysis programFigure 3
Block diagram of the image analysis program. CP – Classifica-
tion Parameters, MOD – Mean Optical Density, NRF – 
Nuclear Roundness Factor, OR – Logical OR operation.
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The differences measured in the intensity of AR expression
in prostate cancer were consistent with previous studies.
Gaston et al. [33] reported higher AR expression in benign
prostate hyperplasia and prostate cancer in African Amer-
icans in a comparison of 25 African Americans and 25
(clockwise)Figure 4
(clockwise). A – Part of the original image, B – Intensity image, C – Image after addition of R, G and B segmented images, D – 
Image after erosion (twice), E – Image after dilation (twice), F – Nuclear mask with intensity information.Page 7 of 9
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also found in malignant glands from a homogenous pop-
ulation of native African men when compared to similar
tissues from Anglo-Saxon Caucasian men [34]. Small
sampling size and non-matched African American and
Caucasian American tissue specimens used in this pilot
study may account for the similarity of AR expression in
benign prostate hyperplasia.
The research need for accurate measurement of AR expres-
sion in archival specimens to dissect the role of AR in
prostate pathology led to a 19 year quest to develop a
robust and automated image analysis system. The system
has been used to measure cellular proliferation, apoptosis
and tumor morphology. The system was also used to
develop a sampling strategy for prostatic tissue microarray
[35]. However extensive user training and computational
knowledge of the operating system was required to oper-
ate the system. The current version of the system is plat-
form independent and can be easily shared across
research groups. The software GUI is intuitive and
requires minimal user training. The system was also found
independent of the imaging system as long as images were
acquired using the same protocol. The constraint in the
current version of the software is the image size. Image
size is required to be a multiple of the segmentation win-
dow (80 × 80 pixels) for optimal performance. The option
to set background to predetermined grayscale value has
made it possible to differentiate regions of protein
proliferation in dual-labeled, paraffin-embedded prostate
tissue [36]. New features added to the system can be made
available to all users by web-based transfer.
Two methods to compute the classification coefficients
are presented. The choice between the two methods
depends on the training set data. If the data is found (or
assumed) to come from multivariate normal distribution,
linear discriminant analysis is computationally more effi-
cient. If the multivariate assumption is violated, logistic
regression should be used [37].
The program performs local segmentation to detect nuclei
and then uses color information to classify nuclei. Linear
discriminant analysis is employed at the outset to gener-
ate classification coefficients. This priori information is
required due to non-standardized immunostaining and
image collection methods across medical institutions and
research laboratories. The addition of classification
parameters to the program customizes the software for the
specimen under study. Nuclear shape information meas-
ured from each nuclear object can be combined with
other morphologic descriptors to predict clinical, diag-
nostic and prognostic outcomes in prostate cancer [13].
This new automated method analyzes an image and pro-
vides reproducible measurements in less than 10 seconds.
The availability of a free, automated system creates new
opportunities for testing, evaluation and use of this image
analysis system by many research groups who study
nuclear protein expression.
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Table 1: Classification Table. AR – Androgen Receptor.
Predicted
Actual Number of AR Positive nuclei Number of AR Negative nuclei
Number of AR positive nuclei (106) 104 (98.11%) 2 (1.89%)
Number of AR negative nuclei (136) 2 (1.47%) 134 (98.53%)
Table 2: Androgen receptor expression in benign prostate and prostate cancer tissue specimens from 20 African Americans and 20 
Caucasian Americans. AA – African American, CA – Caucasian American, BP – Benign Prostate, CaP – Prostate Cancer, P value (two 
sample comparison).
MOD Percent Positive Area Percent Positive Nuclei
CaP BP CaP BP CaP BP
AA 0.34 ± 0.09 0.32 ± 0.06 0.37 ± 0.20 0.45 ± 0.22 0.25 ± 0.15 0.28 ± 0.18
CA 0.25 ± 0.06 0.30 ± 0.08 0.38 ± 0.25 0.35 ± 0.18 0.26 ± 0.12 0.25 ± 0.11
P < 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05 P > 0.05Page 8 of 9
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